Trial intelligence / Profile preview

Herpes Zoster Vaccine Phase 3 Trial in Japan

jRCT2080221246Phase 3Completed

Start
Sep 2010
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01

Overview

Phase 3 trial of Zoster vaccine recombinant in herpes zoster (HZ) (2 arms). Started Sep 2010; status: completed.

02

Drugs

Zoster vaccine recombinant
03

Conditions

herpes zoster (HZ)

Beyond the preview

Go deeper on jRCT2080221246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call